Cel Sci Corporation (CVM)

[Dr. Johnny Fever]

Consider that if CVM were to conduct a new phase III trial for Mk as a treatment for HNSCC (not actually even a remote possibility), in which the treatment arm would only recruit patients who would not receive chemo as part of the SOC (the subset from the IT-MATTERS trial that showed excellent benefits of MK treatment), then that group would be a superset.

I think that the potential for MK is beyond measure here. CVM proved something - that a non-toxic agent can boost the immune system to fight HNSCC and deliver genuine benefit to thousands of people. It's absolutely extraordinary. However, MK was not designed specifically to fight this type of cancer, it was designed to help the immune system recognize and fight tumors. Once they receive approval, there's no telling how many off-label uses MK can/will be applied to. If I were BP, with deep pockets and an eye to the long-game, I would be interested in CVM. But I don't think Geert and co. want to sell. They have an independent streak as long as the PIII trial. I think they would welcome partnerships.